Patient activation can be measured using the Patient Activation Measure (PAM) developed by Hibbard et al, however, little is known about the uses of the PAM in research and in practice. This study aims to explore its differing utility in four UK exemplar sites. Data from four exemplars in a range of health settings with people living with long-term conditions (i.e. stroke or COPD) were evaluated. PAM scores were described and explored in relation to 6 clinical and sociodemographic variables and outcome measures.
- Patient Activation Measure